Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Albuvirtide for Injection Combined With LPV/r for Treatment of HIV-1-Infected Patients Failed First-line Antiretroviral Therapy

NCT02369965 is registered in ClinicalTrials.gov with Frontier Biotechnologies Inc. as lead sponsor.

NCT NCT02369965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02369965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Albuvirtide for Injection Combined With LPV/r for Treatment of HIV-1-Infected Patients Failed First-line Antiretroviral Therapy
Lead sponsor
Frontier Biotechnologies Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 19, 2014
Completion date
April 2, 2018
Enrollment
418 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

aids, hiv infections